Germany-based Freudenberg Group says its sales in China rose by 10% in the third quarter of 2012 to 2.98 billion yuan, compared with the same period of 2011.Furthermore, the group is investing intensively in China and further expanding its activities in the long term. From 2004 to the end of the third quarter of 2012, the group had invested about 2 billion yuan.
Meanwhile, the company’s focus in the country is on medical technology as seen with its recent acquisition of Anura Plastics Engineering in Shenzhen, where the group has invested US$500,000.
Elsewhere in the world, Freudenberg has acquired US-based MedVenture Technology, a manufacturer of medical technology solutions for minimally invasive surgery (MIS). Acquisition activities already started in 2004 when Freudenberg acquired Jenline Industries. In September, Freudenberg inaugurated a new plant in Costa Rica, to add on to its medicaL technology facilities in China, the US, Germany and Ireland. (RJA)